While this option may be less expensive and seems convenient, it’s best to consult a doctor about dosage if you use it, says Joshua J. Neumiller, CDCES, PharmD, the president elect of ...

A single-center pilot study at the Veterans Affairs Hospital/University of Washington in Seattle reported improved verbal memory retention and attention after a three-week test of 20 international ...

The promise all good fountain pens deliver—be they expensive or affordable—is that they make your handwriting better than you ever imagined. At the very least, they make handwriting more fun ...

Novo Nordisk is applying for an expanded US label for its long-acting insulin Tresiba, hoping to gain an upper hand on Sanofi's older rival Lantus. Its data submitted to the FDA shows that ...

This move is a milestone, he noted, as for the first time insulin is being produced as pens inside Egypt, after it was previously produced only in the form of injections. This achievement reflects ...

In our December research highlights, we look at new research into the genetics behind type 2 diabetes in South Asian people, and how new diabetic kidney disease discoveries reveal how the condition ...

There’s nothing quite like using the best fountain pens to get your writing done. The whole experience is rewarding, from purchasing one and unpacking it, to using it for the first time.

Medicare Part D covers diabetic medications, insulin and supplies to inject insulin such as syringes and insulin pens. Medicare Part D will pay for most of your insulin-related coverage including ...

FlexTouch ® is a pre-filled dial-a-dose insulin pen able to deliver from 1 to 80 units in steps of 1 unit. This medicine is not addictive. Ryzodeg ® 70/30 FlexTouch ® is available only with a ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended that Novo Nordisk’s long-acting insulin, Tresiba (degludec), is approved for use in Europe.